Please try another search
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer’s disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Rong Bing Yang | 55 | 2003 | Co-Founder & Vice Executive Chairman |
Dian Bo Liu | 55 | 2003 | Co-Founder, Executive Chairman, CEO and Head of Corporate Directions & Strategies |
Hui Xian Yuan | 62 | 2003 | Co-Founder & Executive Director |
Yuan Yuan Zhu | 40 | 2014 | Executive Director |
Huaqiao Zhang | 58 | 2014 | Independent Non-Executive Director |
Man Kit Leung | 67 | 2014 | Independent Non-Executive Director |
Yuk Lam Lo | 72 | 2014 | Independent Non-Executive Director |
Sze Chung Choy | 62 | 2014 | Independent Non-Executive Director |
Rui Lin Song | 59 | 2017 | Non-Executive Director |
Dong Lyu | 48 | 2023 | Non-Executive Director |
Lian Xia | 44 | 2023 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review